MAGEA4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis

Sheetal Bhan1, Alice Chuang, Sandeep S Negi

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA.

Oncology Reports
|July 31, 2012
PubMed

Insights

Cancer testis antigens (CTAs), like MAGEA4, promote cancer growth by preventing cell cycle arrest and inhibiting apoptosis. This study reveals MAGEA4

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Immunotherapy

Background:

  • Cancer testis antigens (CTAs) are aberrantly expressed in various cancers.
  • MAGEA proteins, a subset of CTAs, are investigated for their roles in cancer.
  • The precise functions of CTAs, including MAGEA4, remain largely undefined.

Purpose of the Study:

  • To investigate the role of MAGEA4 in promoting cancer cell growth.
  • To elucidate the molecular mechanisms by which MAGEA4 influences cell cycle and apoptosis.

Main Methods:

  • Overexpression of MAGEA4 in normal oral keratinocytes (NOK-SI).
  • Analysis of cell cycle progression.
  • Assessment of apoptosis induction (G418-induced).
  • Quantification of p53 downstream gene expression (BAX, CDKN1A).

Main Results:

  • MAGEA4 overexpression promotes the growth of NOK-SI cells.
  • MAGEA4 inhibits G1 phase cell cycle arrest.
  • MAGEA4 suppresses G418-induced apoptosis in NOK-SI cells.
  • Apoptosis inhibition correlates with repression of BAX and CDKN1A.

Conclusions:

  • MAGEA4 promotes cancer cell proliferation by interfering with cell cycle regulation.
  • MAGEA4 exhibits anti-apoptotic functions, potentially through the p53 pathway.
  • Understanding MAGEA4's role provides insights for cancer immunotherapy strategies targeting CTAs.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...